{"disease":{"id":"still-s-disease-adult-onset","name":"still s disease adult onset"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03510442","title":"Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","has_results":false},{"nct_id":"NCT06497491","title":"An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"AO GENERIUM","has_results":false},{"nct_id":"NCT06405152","title":"Assessment of Macrophage Activation syndromE in STill's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT06992505","title":"Assessment of Macrophage Activation syndromE in STill's Disease in Italy","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT05715736","title":"Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Syneos Health","has_results":false},{"nct_id":"NCT07191444","title":"A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT05814159","title":"A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT03265132","title":"A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}